...
Stakeholder group | SHIELD organization | Name of SHIELD member | organization designation |
Industry Entity | Labgnostic, Inc. | Aaron Green | primary |
|
| alternate | |
Epic | Dan Rutz | primary | |
|
| alternate | |
Biomerieux | Xavier Gansel | primary | |
|
| alternate | |
Roche | Nick Decker | primary | |
Roche | Yue Jin | alternate | |
Healthcare Provider | Indiana University/Indiana University Health/Association for Molecular Pathology | Mehdi Nassiri, MD | primary |
University of Wisconsin-Madison | Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA | primary | |
UT Southwestern Medical Center | Hung Luu | primary | |
UNMC | Scott Campbell | primary | |
Tufts Medical Center | Nanguneri Nirmala | primary | |
Sonic Healthcare | Eric Crugnale | primary | |
Former Quest Diagnostics | Collom, Craig D | primary | |
Standards Organization | SNOMED International
| James T. Case | primary |
Monica Harry | alternate | ||
Regenstrief Institute
| Marjorie Rallins | primary | |
Eza Hafeza | alternate | ||
HL7
| Julia Skapik | primary | |
| alternate | ||
Professional Organization | Association of Public Health Laboratories
| Riki Merrick | primary |
Dari Shirazi | alternate | ||
Graphite Health
| Stan Huff | primary | |
| alternate | ||
CAP
| Raj Dash | primary | |
| alternate | ||
AMP
| Robyn Temple | primary | |
| alternate | ||
Governmental - non Voting | CMS | Serafina Brea | primary |
| alternate | ||
ONC | Sara Armson | primary | |
| alternate | ||
CDC | Hubert Vesper (/DDNID/NCEH/DLS) | primary | |
Jasmine Chaitram | alternate | ||
NLM | John Snyder | primary | |
| alternate | ||
FDA |
| primary | |
| alternate | ||
Guest FDA | Brittany Caldwell |
Agenda and Notes
Agenda Item | Notes | ||||
---|---|---|---|---|---|
Quorum evalution (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 18 named members, so 2/3 = 12 (excluding chair and government members) | ||||
Open Meeting | Quorum met at 12:06 | ||||
FDA process for offcially participating in the SHIELD community | Process for selecting FAD representation on community efforts:
Question: Does FDA Collaborative community come with suport - particularly for web presence, collab facilitation like zoom etc?
FDA Collabortive Community presentation from June last year for background | ||||
Feedback from FDA, specifically Collaborative Community leadership in CDRH on our Charter |
Motion to make this adjustment -Hung, Aaron - no further discussion, against: 0, abstain: 0, in favor: 12 This Change was applied after the call today.
| ||||
Call schedule in the summer | June 13th - Andrea will lead - topics:
June 20 - Andrea will lead June 27 - ALL SHIELD call July 4 - need to reschedule - move to July 11th or just cancel?(Xavier and Eza/Marjorie not available) - let’s cancel July 4th | ||||
Meetings | https://loinc.org/conference/atlanta-2023/ October 17-20Plan to submit Andrea submitted abstract | ||||
Took notes directly on the confluence page - focused on question 4 Riki will send reminder email to ALL SHIELD list to either tell us SHIELD should not be submitting comments, or add their thoughts, so that we can wokr on June 13 on craftign the comments and vote on SC call on June 20 (must be near finished then, as that is the deadline for submission). | |||||
Feedback from ONC on Roadmap (FINAL VERSION) | NOT DISCUSSED: Was discussed mentioned on May 30th call - any follow up30 call - here are the comments:
- any volunteers to draft a response / suggested updates in the roadmap? | ||||
Review Working Group Committee list and establish SC representation | NOT DISCUSSED: Created Confluence pages for the 4 priority groups Leads will find call time and invite interested people | ||||
Next call | June 20. 2023 12 -1 PM EDT | ||||
Adjourned | 1:02 PM EDT |
For recording access (SC members only) reach out to Riki
...